Tolterodine
From Wikipedia, the free encyclopedia
Tolterodine
|
|
Systematic (IUPAC) name | |
2-[3-[bis(1-methylethyl)amino]- 1-phenyl-propyl]-4-methyl-phenol | |
Identifiers | |
CAS number | |
ATC code | G04 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C22H31NO |
Mol. mass | 325.488 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | Approximately 96.3%. |
Metabolism | ? |
Half life | 1.9-3.7 hours |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Tolterodine is an antimuscarinic drug that is used to treat urinary incontinence. It is sold under the trade name Detrol.
Tolterodine acts on M2 and M3 subtypes of muscarinic receptors whereas most antimuscarinic treatments for overactive bladder only act on M3 receptors making them more selective. Tolterodine, although it acts on two types of receptors, has fewer side effects than other antimuscarinics eg. oxybutynin (which is selective for M3 only) as tolterodine targets the bladder more than other areas of the body. This means that less drug needs to be given daily (due to efficient targeting of the bladder) and so there are fewer side effects eg. hyposalivation, constipation, decreased gastric motility.
[edit] External links
- Detrol - FDA factsheet.
- Tolterodine
- Tolterodine (patient information)
Urologicals (G04) | |
---|---|
Acidifiers | Ammonium chloride, Calcium chloride |
Urinary antispasmodics | Darifenacin, Emepronium, Flavoxate, Meladrazine, Oxybutynin, Propiverine, Solifenacin, Terodiline, Tolterodine, Trospium |
For erectile dysfunction | Alprostadil, Apomorphine, Avanafil, Moxisylyte, Papaverine, Phentolamine, Sildenafil, Tadalafil, Udenafil, Vardenafil, Vendafidel, Yohimbine |
Other urologicals | Acetohydroxamic acid, Collagen, Dimethyl sulfoxide, Magnesium hydroxide, Phenazopyridine, Phenyl salicylate, Succinimide |
For benign prostatic hypertrophy | 5α-reductase inhibitors: Dutasteride, Finasteride Alpha blockers: Alfuzosin, Doxazosin, Tamsulosin, Terazosin |